The calcium-sensing receptor in bone metabolism: from bench to bedside and back
Authors:
- 23 June 2015
- journal article
- review article
- Published by Springer Nature in Osteoporosis International
- Vol. 26 (8) , 2055-2071
Abstract
The calcium-sensing receptor (CaSR), a key player in the maintenance of calcium homeostasis, can influence bone modeling and remodeling by directly acting on bone cells, as demonstrated by in vivo and in vitro evidence. The modulation of CaSR signaling can play a role in bone anabolism. The calcium-sensing receptor (CaSR) is a key player in the maintenance of calcium homeostasis through the regulation of PTH secretion and calcium homeostasis, thus indirectly influencing bone metabolism. In addition to this role, in vitro and in vivo evidence points to direct effects of CaSR in bone modeling and remodeling. In addition, the activation of the CaSR is one of the anabolic mechanisms implicated in the action of strontium ranelate, to reduce fracture risk. This review is based upon the acquisition of data from a PubMed enquiry using the terms “calcium sensing receptor,” “CaSR” AND “bone remodeling,” “bone modeling,” “bone turnover,” “osteoblast,” “osteoclast,” “osteocyte,” “chondrocyte,” “bone marrow,” “calcilytics,” “calcimimetics,” “strontium,” “osteoporosis,” “skeletal homeostasis,” and “bone metabolism.” A fully functional CaSR is expressed in osteoblasts and osteoclasts, so that these cells are able to sense changes in the extracellular calcium and as a result modulate their behavior. CaSR agonists (calcimimetics) or antagonists (calcilytics) have the potential to indirectly influence skeletal homeostasis through the modulation of PTH secretion by the parathyroid glands. The bone anabolic effect of strontium ranelate, a divalent cation used as a treatment for postmenopausal and male osteoporosis, might be explained, at least in part, by the activation of CaSR in bone cells. Calcium released in the bone microenvironment during remodeling is a major factor in regulating bone cells. Osteoblast and osteoclast proliferation, differentiation, and apoptosis are influenced by local extracellular calcium concentration. Thus, the calcium-sensing properties of skeletal cells can be exploited in order to modulate bone turnover and can explain the bone anabolic effects of agents developed and employed to revert osteoporosis.Keywords
This publication has 121 references indexed in Scilit:
- The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- New concepts in calcium‐sensing receptor pharmacology and signallingBritish Journal of Pharmacology, 2011
- Osteoblast extracellular Ca2+-sensing receptor regulates bone development, mineralization, and turnoverJournal of Bone and Mineral Research, 2011
- An Akt-dependent Increase in Canonical Wnt Signaling and a Decrease in Sclerostin Protein Levels Are Involved in Strontium Ranelate-induced Osteogenic Effects in Human OsteoblastsJournal of Biological Chemistry, 2011
- The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonatesJournal of Bone and Mineral Research, 2010
- Assessing Constitutive Activity of Extracellular Calcium-Sensing Receptors In Vitro and in Bone2010
- Osteoblasts play key roles in the mechanisms of action of strontium ranelateBritish Journal of Pharmacology, 2009
- The Extracellular Calcium-Sensing Receptor (CaSR) Is a Critical Modulator of Skeletal DevelopmentScience Signaling, 2008
- Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutationsBest Practice & Research Clinical Rheumatology, 2008
- Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidismBone, 2007